Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Mishcon de Reya ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Brexit And Life Sciences Update
We last reported on Brexit developments in the May 2018 edition where we focused on the resounding message that the industry still had to prepare for a hard Brexit,
UK
24 Aug 2018
2
Injunctions: An Increasingly Flexible And Pragmatic Approach
In recent years, the UK courts have demonstrated that they are prepared to be flexible and pragmatic when considering remedies for patent infringement.
UK
20 Jul 2018
3
CJEU Rules On Parallel Imports Of Medical Devices
The law relating to the repackaging of imported pharmaceutical products is now largely settled following a series of decisions of the Court of Justice of the European Union (CJEU).
European Union
20 Jul 2018
4
Under The Microscope: The Gender Pay Gap In The Life Sciences Sector
With the first annual reporting window having closed on 4 April 2018, we look at how the life sciences sector has fared in the first year of mandatory gender pay gap reporting.
UK
18 Jul 2018
5
SPC Reform: Commission Proposes Export Manufacturing Waiver
Following its consultation (discussed in our November 2017 edition), the EU Commission has published a proposal for a 'targeted amendment' to the rules relating to supplementary protection certificates (SPCs) ...
European Union
18 Jul 2018
6
Advocate General Issues SPC Opinion In Teva V Gilead
On 25 April, Advocate General Wathelet issued his opinion on the interpretation of Article 3(a) SPC Regulation in the referral from the UK Patents Court in Teva & ors v Gilead ...
European Union
18 Jul 2018
7
Pfizer And Flynn Win Appeal Against Abuse Of Dominance Decision
The Competition Appeal Tribunal (CAT) has upheld appeals by Pfizer Limited and Flynn Pharma Limited in relation to significant fines imposed by the Competition and Markets Authority (CMA) ...
UK
18 Jul 2018
8
A High For Cannabidiol
There has been a huge amount of press interest very recently in medical cannabis, its effects, and whether it should be legalised.
UK
18 Jul 2018
9
Brexit Update – Continue To Prepare For A Hard Brexit
In the last edition of Inside Life Sciences, we reported on the draft EU withdrawal agreement that had been provisionally agreed between the UK and the EU27, including in relation to a proposed transition period ...
UK
31 May 2018
10
Access To Information Held By Health Regulators – Transparency Versus Confidentiality
On 5th February, the EU General Court gave its ruling on three separate cases (PTC Therapeutics v EMA, Pari Pharma v EMA and MSD Animal Health Innovation v EMA) concerning decisions by the European Medicines Agency ...
UK
13 Apr 2018
11
Brexit Update
As the Brexit negotiations continue, the life sciences industry remains vocal. Central to its arguments has been: (1) the need for an agreement that will allow continued co-operation between the UK ...
European Union
13 Apr 2018
12
The Potential Implications Of A Brexit Customs Union On Pharma And Biotech Industries
This would represent a ‘soft Brexit', and would also mean the UK would not be free to strike its own trade deals with non-EU countries.
UK
2 Mar 2018
13
White Paper On The Use Of Social Media By Medical Professionals
Mobile messaging services that market to medical professionals must adhere to the additional security and privacy standards required of this sensitive role.
UK
1 Mar 2018
14
Whatsapp Doc: Legal And Practical Perspectives Of Using Mobile Messaging
With General Data Protection Regulation (GDPR) coming into force in Spring 2018, our guest columnists explore the legal and practical implications of using mobile messengers in the healthcare sector and finding a balance between convenience and compliance.
UK
19 Feb 2018
15
Supplementary Protection Certificates
In October 2017, the European Commission launched a wide-ranging consultation on a 'recalibration' of the EU regime for supplementary protection certificates and patent research exemptions.
European Union
1 Feb 2018
16
Brexit
Of all the IP rights, Brexit has the most limited impact on the existing system of patent protection and enforcement, albeit of course the referendum vote (and the subsequent General Election) ...
European Union
1 Feb 2018
17
Health Apps: Patient Empowerment, But At What Cost?
With the NHS increasingly prescribing health apps that assist with the management of particular health conditions, and Health Secretary, Jeremy Hunt, revealing ambitious plans to provide patients...
UK
28 Nov 2017
18
Civil Litigation: A Proven Tool For The Agrochemicals Industry
Recent reports from Europol regarding the seizure of 122 tonnes of illegal pesticides in the EU highlight that the problem of illegal pesticides is substantial, with no signs of it abating.
UK
28 Nov 2017
19
Using Private Prosecutions To Tackle Counterfeit Drugs
As rights holders, the protection of your brand and IP are of paramount importance.
UK
27 Nov 2017
20
Infliximab: Battle Of The Biosimilars
On 23 May, the CMA issued a statement of objections, which is a provisional finding that Merck Sharp & Dohme Limited (MSD) has breached UK competition law by abusing its dominant position.
UK
27 Nov 2017
Links to Result pages
 
1 2  
>>Next